+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Emergency Contraceptive Pills Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 170 Pages
  • January 2024
  • Region: Global
  • Fairfield Market Research
  • ID: 5927532
Description Jump to:
A recent report on the global emergency contraceptive pills market predicts a subdued growth trajectory over the next five years. From 2024 to 2031, the market is anticipated to experience lackluster expansion.

Factors Dampening Emergency Contraceptive Pill Sales

Several factors are expected to impede the sales of emergency contraceptive pills during the forecast period. Challenges such as time constraints associated with pill intake and potential side effects contribute to this trend.

North America Emerges as the Leading Market

North America is projected to emerge as the largest market for emergency contraceptive pills. Organizations like the International Consortium for Emergency Contraception, based in the United States, are actively promoting the use of emergency contraceptive pills, contributing to the region's dominance.

Combination Pills Maintain Steady Growth

Among the products in the global emergency contraceptive pills market, combination pills are expected to maintain relatively steady growth. These pills are effective in reducing the risk of ectopic pregnancy, ovarian cancer, and premenstrual tension. In 2023, combination pills are estimated to hold approximately 40% of the global market share.

Decline in Demand for Estrogen and Progesterone Pills

In contrast, the demand for estrogen pills is expected to decline rapidly, and by 2031, progesterone pills are also anticipated to lose traction. Side effects such as breast pain, hot flashes, diarrhea, and joint pain associated with progesterone pills are likely to contribute to reduced sales.

Hospital Pharmacies and Drug Stores Dominate Sales Channels

The growth of the global emergency contraceptive pills market will mainly be driven by revenues generated from hospital pharmacies and drug stores. These two sales channels are expected to collectively account for over three-fifths of global revenues. On the other hand, online sales of emergency contraceptive pills are projected to decline, primarily due to the 72-hour time constraint associated with their intake.

Leading Players in the Market

The report profiles key players in the global emergency contraceptive pills market, including Bayer AG, Teva Pharmaceutical Industries Ltd., Piramal Enterprises Limited, HRA Pharma, Mankind Pharma Ltd., Lupin Limited, Richter Gedeon Nyrt, Cooper Pharma, Zhejiang Xianju Pharmaceutical Co., and Pfizer Inc. These manufacturers are expected to focus on research and development to create pills with minimal side effects.

Market Segmentation

Product Type

  • Combination Pills
  • Progesterone Pills
  • Estrogen Pills
  • Other Products

Sales Channel

  • Drug Stores/Pharmacy
  • Hospital Pharmacies
  • Online Traders
  • Other Channels

Region

  • North America
  • Latin America
  • Europe
  • Japan
  • APEJ
  • MEA


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Emergency Contraceptive Pills Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Emergency Contraceptive Pills Market Outlook, 2018 - 2031
3.1. Global Emergency Contraceptive Pills Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Combination Pills
3.1.1.2. Progesterone Pills
3.1.1.3. Estrogen Pills
3.1.1.4. Other Products
3.2. Global Emergency Contraceptive Pills Market Outlook, by Sales Channel, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Drug Stores/ Pharmacy
3.2.1.2. Hospital Pharmacies
3.2.1.3. Online Traders
3.2.1.4. Other Channels
3.3. Global Emergency Contraceptive Pills Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. North America
3.3.1.2. Europe
3.3.1.3. Asia Pacific
3.3.1.4. Latin America
3.3.1.5. Middle East & Africa
4. North America Emergency Contraceptive Pills Market Outlook, 2018 - 2031
4.1. North America Emergency Contraceptive Pills Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Combination Pills
4.1.1.2. Progesterone Pills
4.1.1.3. Estrogen Pills
4.1.1.4. Other Products
4.2. North America Emergency Contraceptive Pills Market Outlook, by Sales Channel, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Drug Stores/ Pharmacy
4.2.1.2. Hospital Pharmacies
4.2.1.3. Online Traders
4.2.1.4. Other Channels
4.3. North America Emergency Contraceptive Pills Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. U.S. Emergency Contraceptive Pills Market by Product Type, Value (US$ Bn), 2018 - 2031
4.3.1.2. U.S. Emergency Contraceptive Pills Market by Sales Channel, Value (US$ Bn), 2018 - 2031
4.3.1.3. Canada Emergency Contraceptive Pills Market by Product Type, Value (US$ Bn), 2018 - 2031
4.3.1.4. Canada Emergency Contraceptive Pills Market by Sales Channel, Value (US$ Bn), 2018 - 2031
4.3.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Emergency Contraceptive Pills Market Outlook, 2018 - 2031
5.1. Europe Emergency Contraceptive Pills Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Combination Pills
5.1.1.2. Progesterone Pills
5.1.1.3. Estrogen Pills
5.1.1.4. Other Products
5.2. Europe Emergency Contraceptive Pills Market Outlook, by Sales Channel, Value (US$ Bn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Drug Stores/ Pharmacy
5.2.1.2. Hospital Pharmacies
5.2.1.3. Online Traders
5.2.1.4. Other Channels
5.3. Europe Emergency Contraceptive Pills Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Germany Emergency Contraceptive Pills Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.2. Germany Emergency Contraceptive Pills Market by Sales Channel, Value (US$ Bn), 2018 - 2031
5.3.1.3. U.K. Emergency Contraceptive Pills Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.4. U.K. Emergency Contraceptive Pills Market by Sales Channel, Value (US$ Bn), 2018 - 2031
5.3.1.5. France Emergency Contraceptive Pills Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.6. France Emergency Contraceptive Pills Market by Sales Channel, Value (US$ Bn), 2018 - 2031
5.3.1.7. Italy Emergency Contraceptive Pills Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.8. Italy Emergency Contraceptive Pills Market by Sales Channel, Value (US$ Bn), 2018 - 2031
5.3.1.9. Turkey Emergency Contraceptive Pills Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.10. Turkey Emergency Contraceptive Pills Market by Sales Channel, Value (US$ Bn), 2018 - 2031
5.3.1.11. Russia Emergency Contraceptive Pills Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.12. Russia Emergency Contraceptive Pills Market by Sales Channel, Value (US$ Bn), 2018 - 2031
5.3.1.13. Rest of Europe Emergency Contraceptive Pills Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.14. Rest of Europe Emergency Contraceptive Pills Market by Sales Channel, Value (US$ Bn), 2018 - 2031
5.3.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Emergency Contraceptive Pills Market Outlook, 2018 - 2031
6.1. Asia Pacific Emergency Contraceptive Pills Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Combination Pills
6.1.1.2. Progesterone Pills
6.1.1.3. Estrogen Pills
6.1.1.4. Other Products
6.2. Asia Pacific Emergency Contraceptive Pills Market Outlook, by Sales Channel, Value (US$ Bn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Drug Stores/ Pharmacy
6.2.1.2. Hospital Pharmacies
6.2.1.3. Online Traders
6.2.1.4. Other Channels
6.3. Asia Pacific Emergency Contraceptive Pills Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. China Emergency Contraceptive Pills Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.2. China Emergency Contraceptive Pills Market by Sales Channel, Value (US$ Bn), 2018 - 2031
6.3.1.3. Japan Emergency Contraceptive Pills Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.4. Japan Emergency Contraceptive Pills Market by Sales Channel, Value (US$ Bn), 2018 - 2031
6.3.1.5. South Korea Emergency Contraceptive Pills Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.6. South Korea Emergency Contraceptive Pills Market by Sales Channel, Value (US$ Bn), 2018 - 2031
6.3.1.7. India Emergency Contraceptive Pills Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.8. India Emergency Contraceptive Pills Market by Sales Channel, Value (US$ Bn), 2018 - 2031
6.3.1.9. Southeast Asia Emergency Contraceptive Pills Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.10. Southeast Asia Emergency Contraceptive Pills Market by Sales Channel, Value (US$ Bn), 2018 - 2031
6.3.1.11. Rest of Asia Pacific Emergency Contraceptive Pills Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.12. Rest of Asia Pacific Emergency Contraceptive Pills Market by Sales Channel, Value (US$ Bn), 2018 - 2031
6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Emergency Contraceptive Pills Market Outlook, 2018 - 2031
7.1. Latin America Emergency Contraceptive Pills Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Combination Pills
7.1.1.2. Progesterone Pills
7.1.1.3. Estrogen Pills
7.1.1.4. Other Products
7.2. Latin America Emergency Contraceptive Pills Market Outlook, by Sales Channel, Value (US$ Bn), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Drug Stores/ Pharmacy
7.2.1.2. Hospital Pharmacies
7.2.1.3. Online Traders
7.2.1.4. Other Channels
7.3. Latin America Emergency Contraceptive Pills Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Brazil Emergency Contraceptive Pills Market by Product Type, Value (US$ Bn), 2018 - 2031
7.3.1.2. Brazil Emergency Contraceptive Pills Market by Sales Channel, Value (US$ Bn), 2018 - 2031
7.3.1.3. Mexico Emergency Contraceptive Pills Market by Product Type, Value (US$ Bn), 2018 - 2031
7.3.1.4. Mexico Emergency Contraceptive Pills Market by Sales Channel, Value (US$ Bn), 2018 - 2031
7.3.1.5. Argentina Emergency Contraceptive Pills Market by Product Type, Value (US$ Bn), 2018 - 2031
7.3.1.6. Argentina Emergency Contraceptive Pills Market by Sales Channel, Value (US$ Bn), 2018 - 2031
7.3.1.7. Rest of Latin America Emergency Contraceptive Pills Market by Product Type, Value (US$ Bn), 2018 - 2031
7.3.1.8. Rest of Latin America Emergency Contraceptive Pills Market by Sales Channel, Value (US$ Bn), 2018 - 2031
7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Emergency Contraceptive Pills Market Outlook, 2018 - 2031
8.1. Middle East & Africa Emergency Contraceptive Pills Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Combination Pills
8.1.1.2. Progesterone Pills
8.1.1.3. Estrogen Pills
8.1.1.4. Other Products
8.2. Middle East & Africa Emergency Contraceptive Pills Market Outlook, by Sales Channel, Value (US$ Bn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Drug Stores/ Pharmacy
8.2.1.2. Hospital Pharmacies
8.2.1.3. Online Traders
8.2.1.4. Other Channels
8.3. Middle East & Africa Emergency Contraceptive Pills Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. GCC Emergency Contraceptive Pills Market by Product Type, Value (US$ Bn), 2018 - 2031
8.3.1.2. GCC Emergency Contraceptive Pills Market by Sales Channel, Value (US$ Bn), 2018 - 2031
8.3.1.3. South Africa Emergency Contraceptive Pills Market by Product Type, Value (US$ Bn), 2018 - 2031
8.3.1.4. South Africa Emergency Contraceptive Pills Market by Sales Channel, Value (US$ Bn), 2018 - 2031
8.3.1.5. Egypt Emergency Contraceptive Pills Market by Product Type, Value (US$ Bn), 2018 - 2031
8.3.1.6. Egypt Emergency Contraceptive Pills Market by Sales Channel, Value (US$ Bn), 2018 - 2031
8.3.1.7. Nigeria Emergency Contraceptive Pills Market by Product Type, Value (US$ Bn), 2018 - 2031
8.3.1.8. Nigeria Emergency Contraceptive Pills Market by Sales Channel, Value (US$ Bn), 2018 - 2031
8.3.1.9. Nigeria Emergency Contraceptive Pills Market Sales Channel, Value (US$ Bn), 2018 - 2031
8.3.1.10. Rest of Middle East & Africa Emergency Contraceptive Pills Market by Product Type, Value (US$ Bn), 2018 - 2031
8.3.1.11. Rest of Middle East & Africa Emergency Contraceptive Pills Market by Sales Channel, Value (US$ Bn), 2018 - 2031
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Product Type vs Sales Channel Heatmap
9.2. Manufacturer vs Sales Channel Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Teva Pharmaceutical Industries Ltd
9.5.1.1. Company Overview
9.5.1.2. Product Type Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Laboratoire HRA Pharma
9.5.2.1. Company Overview
9.5.2.2. Product Type Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Bayer AG
9.5.3.1. Company Overview
9.5.3.2. Product Type Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Xianju Pharmaceutical Co Ltd
9.5.4.1. Company Overview
9.5.4.2. Product Type Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Piramal Enterprises Ltd
9.5.5.1. Company Overview
9.5.5.2. Product Type Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Mankind Pharma Ltd
9.5.6.1. Company Overview
9.5.6.2. Product Type Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Richter Gedeon Nyrt
9.5.7.1. Company Overview
9.5.7.2. Product Type Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Lupin Ltd
9.5.8.1. Company Overview
9.5.8.2. Product Type Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Cooper Pharma
9.5.9.1. Company Overview
9.5.9.2. Product Type Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Pfizer Inc
9.5.10.1. Company Overview
9.5.10.2. Product Type Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
9.5.11. V care Pharma Ltd.
9.5.11.1. Company Overview
9.5.11.2. Product Type Portfolio
9.5.11.3. Financial Overview
9.5.11.4. Business Strategies and Development
9.5.12. Paras Pharmaceuticals Ltd.
9.5.12.1. Company Overview
9.5.12.2. Product Type Portfolio
9.5.12.3. Financial Overview
9.5.12.4. Business Strategies and Development
9.5.13. Cipla Limited
9.5.13.1. Company Overview
9.5.13.2. Product Type Portfolio
9.5.13.3. Financial Overview
9.5.13.4. Business Strategies and Development
9.5.14. Zee Laboratories
9.5.14.1. Company Overview
9.5.14.2. Product Type Portfolio
9.5.14.3. Financial Overview
9.5.14.4. Business Strategies and Development
9.5.15. Hill Life Care Ltd.
9.5.15.1. Company Overview
9.5.15.2. Product Type Portfolio
9.5.15.3. Financial Overview
9.5.15.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Teva Pharmaceutical Industries Ltd.
  • Bayer AG, HRA Pharma
  • Piramal Enterprises Limited
  • Mankind Pharma Ltd.
  • Richter Gedeon Nyrt
  • Lupin Limited
  • Cooper Pharma
  • Pfizer Inc.
  • Zhejiang Xianju Pharmaceutical Co.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Emergency Contraceptive Pills Market by Type, Distribution Channel, and Region 2023-2028 - Product Image

Emergency Contraceptive Pills Market by Type, Distribution Channel, and Region 2023-2028

  • Report
  • 143 Pages
  • Global
From
Emergency Contraceptive Pills - Global Strategic Business Report - Product Image

Emergency Contraceptive Pills - Global Strategic Business Report

  • Report
  • 246 Pages
  • Global
From
Global Emergency Contraceptive Pills Market by Type (Antiprogestin, Combination Pills, Progesterone Pills), Category (Branded, Generic), Age Group, Distribution - Forecast 2024-2030 - Product Image

Global Emergency Contraceptive Pills Market by Type (Antiprogestin, Combination Pills, Progesterone Pills), Category (Branded, Generic), Age Group, Distribution - Forecast 2024-2030

  • Report
  • 192 Pages
  • Global
From
Emergency Contraceptive Pills Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Emergency Contraceptive Pills Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 190 Pages
  • Global
From
Emergency Contraceptives Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Emergency Contraceptives Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 90 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.